From the Journals

ICYMI: Hereditary cancer screening feasible in community gynecologic practices


 

FROM OBSTETRICS & GYNECOLOGY

After a group of community obstetrics and gynecology practices underwent training in hereditary cancer screening, genetic testing rates increased by four times over the immediate preintervention rate and by eight times over the year prior to intervention, according to results of a prospective process intervention study published in Obstetrics & Gynecology (2018 Oct 5. doi: 10.1097/AOG.0000000000002916).

We covered this story before it was published in the journal. Find our conference coverage at the link below.

Recommended Reading

New multi-analyte blood test shows promise in screening for several common solid tumors
Breast Cancer ICYMI
STUDY: More mammograms after cost-sharing elimination
Breast Cancer ICYMI
How does oral contraceptive use affect one’s risk of ovarian, endometrial, breast, and colorectal cancers?
Breast Cancer ICYMI
VIDEO: Office-based hereditary cancer risk testing is doable
Breast Cancer ICYMI
Universal BRCA testing worthwhile for relatives of high-grade serous ovarian cancer patients
Breast Cancer ICYMI
Does hormone therapy increase breast cancer risk in BRCA1 mutation carriers?
Breast Cancer ICYMI
Herceptin linked to doubling of HF risk in women with breast cancer
Breast Cancer ICYMI
Agrees that OC use clearly reduces mortality
Breast Cancer ICYMI
Breast cancer risk in type 2 diabetes related to adiposity
Breast Cancer ICYMI
New and promising GSM treatments, more clinical takeaways from NAMS 2018
Breast Cancer ICYMI